Lvm Capital Management LTD Vertex Pharmaceuticals Inc Transaction History

Lvm Capital Management LTD

$869 Million
Q3 2024

A detailed history of Lvm Capital Management LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Lvm Capital Management LTD holds 30,013 shares of VRTX stock, worth $13.9 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares

30,013

Previous 30,013 -0.0%

Holding current value

$13.9 Million

Previous $14.1 Million 0.77%

% of portfolio

1.61%

Previous 1.6%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$392.81 - $485.53 $157,909 - $195,183	-402 Reduced 1.32%	30,013 $14.1 Million
Q1 2024 Apr 15, 2024	BUY	$407.69 - $446.08 $128,422 - $140,515	315 Added 1.05%	30,415 $12.7 Million
Q4 2023 Jan 12, 2024	BUY	$343.0 - $410.68 $15,435 - $18,480	45 Added 0.15%	30,100 $12.2 Million
Q3 2023 Oct 10, 2023	BUY	$338.18 - $362.46 $228,271 - $244,660	675 Added 2.3%	30,055 $10.5 Million
Q2 2023 Jul 07, 2023	SELL	$314.42 - $351.91 $361,583 - $404,696	-1,150 Reduced 3.77%	29,380 $10.3 Million
Q1 2023 Apr 17, 2023	SELL	$283.23 - $323.1 $733,565 - $836,829	-2,590 Reduced 7.82%	30,530 $9.62 Million
Q4 2022 Jan 03, 2023	SELL	$285.76 - $321.48 $354,342 - $398,635	-1,240 Reduced 3.61%	33,120 $9.56 Million
Q3 2022 Oct 05, 2022	SELL	$273.83 - $305.53 $585,996 - $653,834	-2,140 Reduced 5.86%	34,360 $9.95 Million
Q2 2022 Jul 14, 2022	BUY	$234.96 - $292.55 $795,104 - $989,989	3,384 Added 10.22%	36,500 $10.3 Million
Q1 2022 Apr 13, 2022	BUY	$221.42 - $260.97 $281,203 - $331,431	1,270 Added 3.99%	33,116 $8.64 Million
Q4 2021 Jan 04, 2022	BUY	$177.01 - $223.45 $56,820 - $71,727	321 Added 1.02%	31,846 $6.99 Million
Q3 2021 Oct 05, 2021	BUY	$181.39 - $202.99 $116,996 - $130,928	645 Added 2.09%	31,525 $5.72 Million
Q2 2021 Jul 08, 2021	BUY	$187.49 - $221.1 $317,795 - $374,764	1,695 Added 5.81%	30,880 $6.23 Million
Q1 2021 Apr 06, 2021	BUY	$207.02 - $241.31 $82,808 - $96,524	400 Added 1.39%	29,185 $6.27 Million
Q4 2020 Jan 11, 2021	BUY	$207.01 - $276.09 $5.96 Million - $7.95 Million	28,785 New	28,785 $6.8 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lvm Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lvm Capital Management LTD with notifications on news.

Account

Lvm Capital Management LTD Vertex Pharmaceuticals Inc Transaction History